Zhang, S., Li, L., Wang, T., Bian, L., Hu, H., Xu, C., . . . Jiang, Z. (2016). Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients. BMC Cancer.
Citação norma ChicagoZhang, Shaohua, et al. "Real-time HER2 Status Detected On Circulating Tumor Cells Predicts Different Outcomes of Anti-HER2 Therapy in Histologically HER2-positive Metastatic Breast Cancer Patients." BMC Cancer 2016.
Citação norma MLAZhang, Shaohua, et al. "Real-time HER2 Status Detected On Circulating Tumor Cells Predicts Different Outcomes of Anti-HER2 Therapy in Histologically HER2-positive Metastatic Breast Cancer Patients." BMC Cancer 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.